Targeted Cancer Therapy is a personalized approach to cancer treatment that focuses on specific genetic, molecular, or biological changes found in cancer cells. It may be recommended when testing identifies a target that can be addressed with a suitable targeted medicine.
Before treatment, the oncology team may review the patient's diagnosis, cancer type, stage, previous treatments, overall health, and relevant biomarker or molecular test results. This helps determine whether targeted therapy is an appropriate option.
Targeted therapy can be used for selected cancers, including certain solid tumors and blood cancers. Depending on the individual case, it may be used alone or alongside chemotherapy, immunotherapy, radiation therapy, surgery, or other treatments.
The treatment plan is personalized according to the patient's medical condition and test results. Medicines may be administered orally or intravenously, depending on the therapy prescribed by the treating specialist.
Regular follow-up is important during targeted cancer treatment. Doctors may monitor treatment response, blood tests, imaging results, and potential side effects to determine whether treatment should be continued or adjusted.
Our Targeted Cancer Therapy Package supports patients through a coordinated treatment pathway, with specialist evaluation and appropriate investigations based on individual requirements. Treatment decisions are made by the medical team after reviewing the patient's complete clinical information.